SCHEMBL6466800

SCHEMBL6466800

Cc1csc(C2CCCN2C(=O)c2cc(-c3nnc(C(C)(Cc4ccccc4)NC(=O)OC(C)(C)C)o3)cc(OS(=O)(=O)C(F)(F)F)n2)n1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.34
ACE P12821 1/20 0.32
TRPV1 Q8NER1 3/20 0.32
HCRTR1 O43613 4/20 0.32
HCRTR2 O43614 4/20 0.32
KLK5 Q9Y337 1/20 0.32
BACE1 P56817 1/20 0.31
CPT2 P23786 1/20 0.31
CPT1A P50416 1/20 0.31
CPT1B Q92523 1/20 0.31
POLB P06746 1/20 0.31
CMA1 P23946 2/20 0.31
TRPC3 Q13507 1/20 0.30
TRPC6 Q9Y210 1/20 0.30
PKM P14618 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
MAPT P10636 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467781 0.92 SMN1; SMN2 (0.36) SMN1; SMN2ACETRPV1HCRTR1HCRTR2
SCHEMBL2725564 0.90 SMN1; SMN2 (0.34) SMN1; SMN2ACETRPV1HCRTR1HCRTR2
SCHEMBL2725565 0.90 SMN1; SMN2 (0.34) SMN1; SMN2ACETRPV1HCRTR1HCRTR2
SCHEMBL6468229 0.87 BACE1 (0.37) SMN1; SMN2ACETRPV1HCRTR1HCRTR2
SCHEMBL10290109 0.87
SCHEMBL2726988 0.87 SMN1; SMN2 (0.38) SMN1; SMN2TRPV1HCRTR1HCRTR2CPT2
SCHEMBL6468770 0.85 SMN1; SMN2 (0.37) SMN1; SMN2ACETRPV1HCRTR1HCRTR2
SCHEMBL10289972 0.84 USP30 (0.37) SMN1; SMN2ACETRPV1HCRTR1HCRTR2
SCHEMBL2729431 0.83 CPT1A (0.40) SMN1; SMN2ACETRPV1KLK5CPT2
SCHEMBL10290121 0.82 SCD5 (0.36) ACEHCRTR1HCRTR2KLK5CPT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054510-A1 OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2012-04-26 WO disclosed